Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: University Hospital Tuebingen
Woman and Man Max 99 years
University Hospital Tuebingen
Update Il y a 4 ans
A double-blind randomized study to determine the effect of empagliflozin versus placebo on brain insulin sensitivity in patients with prediabetes
Key objective: to assess the effect of treatment with 25 mg empagliflozin daily versus placebo on regional brain insulin sensitivity. Effect of 8 weeks treatment with 25 mg empagliflozin or placebo ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
University Hospital Tuebingen
Update Il y a 4 ans
Vaccination against childhood leukemia
Primary objective is to evaluate the safety, clinical toxicity and in vivo immunological effects of a patient-individualized peptide vaccination in pediatric patients with acute lymphoblastic leukemia...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
University Hospital Tuebingen
Update Il y a 4 ans
iVAC-L-CLL01: Patient-Individulaized Peptide Vaccination in Combination with Lenalidomide afetr First Line Therapy of CLL iVAC-L-CLL01: Individualisierte Peptid-Impfung in Kombination mit Lenalidomid nach First-Line- Therapie der CLL
The aim of this study is to induce a peptide-specific immune response in CLL patients by multi-peptide vaccination with a patient-individualized peptide cocktail and, dependent on MRD status, the immu...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
University Hospital Tuebingen
Update Il y a 4 ans
Entwicklung einer Untersuchungsmethode zur Bestimmung des NO-Transferfaktors der Lunge Evaluierung der Methode und Normwerterhebung an gesunden Probanden (Development of a new method for steady-state measurement of NO lung diffusing capacity in healthy subjects)
Main objective of the clinical trial is the evaluation of a new method (nitric oxide multiple breath) for measuring lung diffusion capacity in comparison to a standard method (single-breath carbon mon...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
University Hospital Tuebingen
Update Il y a 4 ans
Transplantation of stem cells for the treatment of svere systemic sclerosis with a protocol which is adapted to individual manifestatons of the disease Transplantation von Stammzellen bei schwerer Sklerodermie mit einem Protokoll, das sich an die jeweiligen Organbeteiligungen anpasst
To optimise the treatment for severe systemic sclerosis with high dose chemotherapy and autologous stem cell transplantation by adapting the procedure to the individual organ manifestation.
Country
None
organs
None
Specialty
None
unknown
More information
University Hospital Tuebingen (Germany)
Update Il y a 4 ans
Cognitive behavioural treatment for persistent positive symptoms in psychotic disorders
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
University Hospital Tuebingen
Update Il y a 4 ans
Étude NEO-VC : étude de phase 2, évaluant l’efficacité et la tolérance d’un traitement néoadjuvant associant le vémurafénib et le cobimetinib (GDC-0973), chez des patients ayant un mélanome malin à métastase isolée. [essai clos aux inclusions]
ETUDE NEO-VC : Traitement néo-adjuvant avec combinaison de Vemurafenib et de Cobimetinib (GDC-0973) dans le traitement du mélanome malin à métastase isolée (AJCC stade IIIC / IV) et étude des biomarqu...
Country
France
organs
Mélanomes cutanés
Specialty
Thérapies Ciblées
,
Immunothérapie - Vaccinothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
University Hospital Tuebingen (Germany)
Update Il y a 4 ans
Cognitive behavioural treatment of negative symptoms in patients with schizophrenic disorders
Not provided at time of registration
Country
Germany
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
University Hospital Tuebingen
Update Il y a 6 ans
Étude NEO-VC : étude de phase 2, évaluant l’efficacité et la tolérance d’un traitement néoadjuvant associant le vémurafénib et le cobimetinib (GDC-0973), chez des patients ayant un mélanome malin à métastase isolée.
ETUDE NEO-VC : Traitement néo-adjuvant avec combinaison de Vemurafenib et de Cobimetinib (GDC-0973) dans le traitement du mélanome malin à métastase isolée (AJCC stade IIIC / IV) et étude des biomarqu...
Country
France
organs
Mélanomes cutanés
Specialty
Thérapies Ciblées
,
Immunothérapie - Vaccinothérapie
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
University Hospital Tuebingen
Update Il y a 4 ans
Apixaban zur Behandlung des emabilischen Schlafanfalls unbekannten Ursprungs Apixaban zur Behandlung des emabilischen Schlafanfalls unbekannten Ursprungs
The primary endpoint will be the occurrence of at least one new ischemic lesion identified by magnetic resonance imaging (axial T2-weighted fluid attenuated inversion recovery MRI (FLAIR) and/ or axia...
Country
None
organs
None
Specialty
None
unknown
More information